diabetes
Reports raise fresh Avandia safety questions
February 23, 2010Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes
GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …
Roche diabetes trial proves promising
February 11, 2010Research and Development GLP-1, Roche, diabetes, taspoglutide
Phase III results for Roche’s once-weekly injectable drug taspoglutide have shown a positive effect on reducing blood glucose compared with …
Lilly signs diabetes deal with Alizé Pharma
February 2, 2010Research and Development Alize, diabetes, lilly, type II
Lilly has signed a new research and licensing deal with Lyon-based Alizé Pharma to develop Alizé’s AZP-01 programme, focused on …
Digital Pharma: Glucose monitoring for the Nintendo generation
January 20, 2010Medical Communications Bayer, diabetes, digi, digi game, digital pharma
The Nintendo DS that arrived in our house on Christmas has already become my eldest son’s most favourite present of …
Victoza pill trial begins
January 19, 2010Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Victoza, diabetes, type II
A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …
Digital Pharma: Virtual diabetes patient community launched on Second Life
January 13, 2010Medical Communications Diabetes UK, Second Life, diabetes, digital pharma
Patient group Diabetes UK has, quite literally, set up shop on Second Life, establishing its own office in the online …
Boehringer prepares for diabetes launch
December 3, 2009Medical Communications Boehringer, DPP-4, diabetes
Boehringer Ingelheim has hired the London arm of international PR agency Weber Shandwick to handle the UK launch of its …
AZ-BMS launch Onglyza in Europe
October 19, 2009Sales and Marketing AZ, BMS, DPP-4, Onglyza, diabetes
Bristol-Myers Squibb and AstraZeneca’s long-awaited type II diabetes drug Onglyza has been launched in the UK, its first European market.Designed …
US approval for Onglyza
August 6, 2009Research and Development, Sales and Marketing AZ, BMA, diabetes
Adult type II diabetes treatment Onglyza has been approved by the US Food and Drug Administration. Co-marketed by AstraZeneca and …
Victoza launched in UK
July 9, 2009Sales and Marketing Victoza, diabetes
Novo Nordisk this week launched its much-anticipated type II diabetes treatment Victoza in the UK. Victoza (liraglutide) is the first …
Sanofi moves to quell Lantus safety concerns
July 7, 2009Research and Development, Sales and Marketing Lantis, Sanofi-Aventis, diabetes
Sanofi-Aventis has rejected claims of a possible connection between its diabetes treatment Lantus and cancer. The possible link was reported …
BMS and AZ launch diabetes patient survey
June 19, 2009Medical Communications, Sales and Marketing diabetes
Bristol-Myers Squibb and AstraZeneca have joined forces with Diabetes UK to launch a national patient survey on the effects of …
Genentech forms type I diabetes collaboration
June 11, 2009Research and Development Roche, diabetes
The deal gives the Roche-owned biotech development and marketing rights to Bayhill’s molecule BHT-3021, which is currently in phase I/II …
